Atlas Trials

A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer

Clinical trial NCT02402036 · TERMINATED

Trial details

NCT number
NCT02402036
Sponsor
Georgetown University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Colon Cancer
Start date
2015-02-01
Primary completion
2017-11-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.